A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

Abstract excerpt

Neutralizing antibodies could potentially be used as antivirals against the coronavirus disease 2019 (COVID-19) pandemic. Here, we report isolation of four human-origin monoclonal antibodies from a convalescent patient, all of which display neutralization abilities. The antibodies B38 and H4 block binding between the spike glycoprotein receptor binding domain (RBD) of the virus and the cellular receptor...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to COVID-19 Clinical Research Studies
• Share to COVID-19 Impact on Reproduction
• Share to SARS-CoV-2 and COVID-19 Research